Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation

Sponsor
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan (Other)
Overall Status
Recruiting
CT.gov ID
NCT04254250
Collaborator
(none)
350
2
72
175
2.4

Study Details

Study Description

Brief Summary

This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia.

The current study is prospective observational study to evaluate the efficacy of preoperative estimation of disc herniation recurrence among patients with lumbar disc herniation using predictive mathematical model at terms 3 years postoperatively .

It is expected to enroll 350 patients aged 18-70 with lumbar disc herniation. Risk estimation of disc herniation recurrence will be evaluated preoperatively, then patient will undergo conventional microdiscectomy. Postoperative eximanation will include Visits every 6-months during 3 years to evaluate clinical outcomes.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Preoperative risk estimation of disc herniation recurrence

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
350 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observational Cohort Study Of The Efficacy Of Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation
Actual Study Start Date :
Feb 10, 2020
Anticipated Primary Completion Date :
Feb 10, 2023
Anticipated Study Completion Date :
Feb 10, 2026

Arms and Interventions

Arm Intervention/Treatment
High risk recurrence group

Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.

Diagnostic Test: Preoperative risk estimation of disc herniation recurrence
Risk estimation of disc herniation recurrence will be evaluated preoperatively, depend on the risk significance each patient will be assigned to one of two groups - with high risk and low risk. Then each patient will undergo conventional one-level microdiscectomy.

Low risk recurrence group

Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.

Diagnostic Test: Preoperative risk estimation of disc herniation recurrence
Risk estimation of disc herniation recurrence will be evaluated preoperatively, depend on the risk significance each patient will be assigned to one of two groups - with high risk and low risk. Then each patient will undergo conventional one-level microdiscectomy.

Outcome Measures

Primary Outcome Measures

  1. Reherniation rate [at 3 years follow-up term postoperatively]

    Rate of lumbar disc reherniation, symptomatic presence of disc herniation confirmed by MRI at the previously operated level and side

Secondary Outcome Measures

  1. Improvement of Oswestry Disability Index (ODI) [6, 12, 18, 24, 30, 36 months follow up]

    To observe the improvement of ODI as compared to baseline through follow-up terms Oswestry Disability Index - patient-reported physical and household activity. Minimum - 0 % (the best result, the patient has no limitations in physical activity). Maximum - 100% (the worst result, patient is not physically active at all).

  2. Improvement of Visual analog scale (VAS) leg pain intensity [6, 12, 18, 24, 30, 36 months follow up]

    To observe the improvement of VAS leg pain as compared to baseline through follow-up terms.

  3. Change from baseline in EQ-5D (EuroQl - 5 dimensional) [6, 12, 18, 24, 30, 36 months follow up]

    To observe change in EQ-5Dl as compared to baseline

  4. HTI Item (from SF-36) [6, 12, 18, 24, 30, 36 months follow up]

    To observe the HTI Item (from SF-36) as compared to baseline

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 to 60 years;

Single level lumbar disc herniation with neural compression confirmed on MRI at one level of L4-L5 or L5-S1;

  1. Radicular leg pain with or without back pain;

  2. Symptoms persisting for at least four weeks prior to surgery;

  3. Given written Informed Consent;

  4. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;

  5. Visual Analogue Scale score at least 40/100 at baseline.

Exclusion Criteria:
  1. More than one symptomatic level requiring multilevel surgical decompression

  2. Stenosis any etiology at the same level;

  3. Spondylolisthesis any etiology at the same level;

  4. Prior lumbar spinal surgery at any level;

  5. Other non-degenerative spinal conditions (e.g. infectious, traumatic, metabolic, inflammatory, neoplastic, structural or other pathology) that may have an impact on subject safety, wellbeing or the intent and conduct of the study

  6. Concurrent participation in another clinical study that may confound study results.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Priorov National Medical Research Center of Traumatology and Orthopedics Moscow Russian Federation 127299
2 Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan Novosibirsk Russian Federation 630091

Sponsors and Collaborators

  • Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan
ClinicalTrials.gov Identifier:
NCT04254250
Other Study ID Numbers:
  • NS02-03
First Posted:
Feb 5, 2020
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022